公开发售
Sichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $6.72 million Secondary Public Offering of Novabay Pharmaceuticals, Inc.
NovaBay Pharmaceuticals, Inc.
$6,720,000
Secondary Public Offering
Common Stock & Warrants
March 2014
Read MoreSichenzia Ross Friedman Ference LLP Advises Brean Capital LLC on $ 6.5 million Registered Direct Offering of ClearSign Combustion Corporation
SMTP, Inc.
Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals in $43.5 Million Shelf Takedown
Intellicheck Mobilisa
Medovex Corp. Announces $8.0 M IPO
Medovex Corporation
$8,000,000
Initial Public Offering
Common Stock and Warrants
December 2014
Read MoreSichenzia Ross Friedman Ference LLP Advises Laidlaw & Company on $20 Million Public Offering of Spherix Inc.
Spherix, Inc.
$20,000,000
Represented Sole Placement Agent
Public Offering
Preferred Stock
June 2014
Read MoreOculus Innovative Sciences, Inc.
not assigned 證券法
Read MoreTonix Pharmaceuticals
not assigned 證券法
Read MoreEvoke Pharma, Inc.
not assigned 證券法
Read More
